Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium - 16/08/11
, Anne Muñoz-Furlong, BA b, Ronna L. Campbell, MD, PhD c, N. Franklin Adkinson, MD d, S. Allan Bock, MD e, Amy Branum, MSPH f, Simon G.A. Brown, MBBS, PhD g, Carlos A. Camargo, MD h, Rita Cydulka, MD, MS i, Stephen J. Galli, MD j, Jane Gidudu, MD, MPH k, Rebecca S. Gruchalla, MD l, Allen D. Harlor, MD m, David L. Hepner, MD n, Lawrence M. Lewis, MD o, Phillip L. Lieberman, MD p, Dean D. Metcalfe, MD q, Robert O’Connor, MD r, Antonella Muraro, MD, PhD s, Amanda Rudman, BA q, Cara Schmitt, MS b, Debra Scherrer, BA b, F. Estelle R. Simons, MD t, Stephen Thomas, MD, MPH u, Joseph P. Wood, MD v, Wyatt W. Decker, MD c
Reprint requests: Hugh A. Sampson, MD, Division of Pediatric Allergy and Immunology, Mount Sinai Hospital, One Gustave L. Levy Pl, Box 1198, New York, NY 10029-6574.New York, NY, Fairfax, Va, Rochester, Minn, Baltimore, Hyattsville, and Bethesda, Md, Boulder and Denver, Colo, Fremantle, Australia, Boston, Mass, Cleveland, Ohio, Stanford, Calif, Lilbum, Ga, Dallas, Tex, Eugene, Ore, St Louis, Mo, Cordova, Tenn, Padua, Italy, Winnipeg, Manitoba, Canada, and Scottsdale, Ariz
Abstract |
There is no universal agreement on the definition of anaphylaxis or the criteria for diagnosis. In July 2005, the National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network convened a second meeting on anaphylaxis, which included representatives from 16 different organizations or government bodies, including representatives from North America, Europe, and Australia, to continue working toward a universally accepted definition of anaphylaxis, establish clinical criteria that would accurately identify cases of anaphylaxis with high precision, further review the evidence on the most appropriate management of anaphylaxis, and outline the research needs in this area.
Le texte complet de cet article est disponible en PDF.Key words : Anaphylaxis, IgE-mediated hypersensitivity, anaphylactoid, epinephrine
Abbreviations used : FAAN, NIAID
Plan
Vol 117 - N° 2
P. 391-397 - février 2006 Retour au numéro
Article précédent
- Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005
- A. Taïeb (Bordeaux, France), A. Giannetti (Modena, Italy), K. Thestrup-Pedersen (Aarhus, Denmark), J. Ring (Munich, Germany), Alain Taïeb, Jon Hanifin, Kevin Cooper, Jan D. Bos, Genji Imokawa, Tim J. David, Johannes Ring, Carlo Gelmetti, Alexander Kapp, Masutaka Furue, Yves de Prost, Ulf Darsow, Thomas Werfel, David Atherton, Arnold P. Oranje
- Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis
- Mutasem M. Rawas-Qalaji, F. Estelle R. Simons, Keith J. Simons
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?